{"id":"https://openalex.org/W2015069495","doi":"https://doi.org/10.1007/s12325-010-0040-7","title":"Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies","display_name":"Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W2015069495","doi":"https://doi.org/10.1007/s12325-010-0040-7","mag":"2015069495","pmid":"https://pubmed.ncbi.nlm.nih.gov/20556559"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-010-0040-7","doi":"https://doi.org/10.1007/s12325-010-0040-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12325-010-0040-7","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015069495"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Lakshmi Pillai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267050","display_name":"Primus Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/00ze9m022","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi Pillai","raw_affiliation_strings":["Primus Pharmaceuticals, Inc., Scottsdale, AZ 85251, USA","Primus Pharmaceuticals, Inc., Scottsdale, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., Scottsdale, AZ 85251, USA","institution_ids":["https://openalex.org/I4405267050"]},{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., Scottsdale, USA","institution_ids":["https://openalex.org/I4405267050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103223501","display_name":"Robert M. Levy","orcid":"https://orcid.org/0000-0002-2736-4096","observed_orcids":["https://orcid.org/0000-0002-2736-4096"]},"institutions":[{"id":"https://openalex.org/I4405267050","display_name":"Primus Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/00ze9m022","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Levy","raw_affiliation_strings":["Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Rd, Suite 200, Scottsdale, AZ, 85251, USA","Primus Pharmaceuticals, Inc., Scottsdale, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Rd, Suite 200, Scottsdale, AZ, 85251, USA","institution_ids":["https://openalex.org/I4405267050"]},{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., Scottsdale, USA","institution_ids":["https://openalex.org/I4405267050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001659235","display_name":"Mesfin Yimam","orcid":"https://orcid.org/0000-0001-5009-1586","observed_orcids":["https://orcid.org/0000-0001-5009-1586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mesfin Yimam","raw_affiliation_strings":["Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","Unigen Pharmaceuticals, Inc., Lacey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","institution_ids":[]},{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., Lacey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100761669","display_name":"Yuan Zhao","orcid":"https://orcid.org/0000-0002-7045-138X","observed_orcids":["https://orcid.org/0000-0002-7045-138X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Zhao","raw_affiliation_strings":["Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","Unigen Pharmaceuticals, Inc., Lacey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","institution_ids":[]},{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., Lacey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100770534","display_name":"Qi Jia","orcid":"https://orcid.org/0000-0002-8124-8432","observed_orcids":["https://orcid.org/0000-0002-8124-8432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Jia","raw_affiliation_strings":["Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","Unigen Pharmaceuticals, Inc., Lacey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., 2660 Willamette Drive, NE, Lacey, WA, 98516, USA","institution_ids":[]},{"raw_affiliation_string":"Unigen Pharmaceuticals, Inc., Lacey, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089767525","display_name":"Bruce P. Burnett","orcid":"https://orcid.org/0000-0001-5800-6622","observed_orcids":["https://orcid.org/0000-0001-5800-6622"]},"institutions":[{"id":"https://openalex.org/I4405267050","display_name":"Primus Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/00ze9m022","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267050"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bruce P. Burnett","raw_affiliation_strings":["Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Rd, Suite 200, Scottsdale, AZ, 85251, USA","Primus Pharmaceuticals, Inc., Scottsdale, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Rd, Suite 200, Scottsdale, AZ, 85251, USA","institution_ids":["https://openalex.org/I4405267050"]},{"raw_affiliation_string":"Primus Pharmaceuticals, Inc., Scottsdale, USA","institution_ids":["https://openalex.org/I4405267050"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089767525"],"corresponding_institution_ids":["https://openalex.org/I4405267050"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.1207,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.75564939,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"27","issue":"6","first_page":"400","last_page":"411"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.18850000202655792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.09139999747276306,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclooxygenase-inhibition","display_name":"cyclooxygenase inhibition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/5-lipoxygenase-inhibition","display_name":"5-lipoxygenase inhibition","score":0.9629999995231628},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.671999990940094},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.8080000281333923},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.7720000147819519},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/thromboxane","display_name":"thromboxane","score":0.9319999814033508},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8529999852180481},{"id":"https://openalex.org/keywords/secondary-hemostasis","display_name":"secondary hemostasis","score":0.8289999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8941689133644104},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.8748629093170166},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.7106110453605652},{"id":"https://openalex.org/C2778589496","wikidata":"https://www.wikidata.org/wiki/Q487937","display_name":"Hemostasis","level":2,"score":0.6571723818778992},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6324378252029419},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5932049751281738},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.5811872482299805},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.5550304055213928},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5120975971221924},{"id":"https://openalex.org/C2781080829","wikidata":"https://www.wikidata.org/wiki/Q3009646","display_name":"Thromboxane B2","level":3,"score":0.49124211072921753},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.442674845457077},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4281250834465027},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.41689634323120117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.352492094039917},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17845773696899414},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10479119420051575},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09811124205589294},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06296408176422119},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.06284096837043762},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001094","descriptor_name":"Arachidonate 5-Lipoxygenase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001760","descriptor_name":"Bleeding Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019934","descriptor_name":"International Normalized Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051545","descriptor_name":"Cyclooxygenase 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12325-010-0040-7","doi":"https://doi.org/10.1007/s12325-010-0040-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12325-010-0040-7","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmid:20556559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20556559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Controlled Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W86417293","https://openalex.org/W207782751","https://openalex.org/W251017256","https://openalex.org/W339775214","https://openalex.org/W1565253767","https://openalex.org/W1570617919","https://openalex.org/W1811438153","https://openalex.org/W1835823881","https://openalex.org/W1964437706","https://openalex.org/W1980642987","https://openalex.org/W1983759759","https://openalex.org/W1988830927","https://openalex.org/W1989081972","https://openalex.org/W1992650719","https://openalex.org/W1997323294","https://openalex.org/W1998551599","https://openalex.org/W2011327495","https://openalex.org/W2011941025","https://openalex.org/W2017818343","https://openalex.org/W2024638019","https://openalex.org/W2025198200","https://openalex.org/W2026589095","https://openalex.org/W2034444864","https://openalex.org/W2037942670","https://openalex.org/W2050620617","https://openalex.org/W2053059498","https://openalex.org/W2057721190","https://openalex.org/W2061142443","https://openalex.org/W2066905319","https://openalex.org/W2067534447","https://openalex.org/W2074052064","https://openalex.org/W2084054008","https://openalex.org/W2087282099","https://openalex.org/W2090838806","https://openalex.org/W2096179188","https://openalex.org/W2100133935","https://openalex.org/W2100822604","https://openalex.org/W2107171211","https://openalex.org/W2109453128","https://openalex.org/W2115899272","https://openalex.org/W2130316297","https://openalex.org/W2139347309","https://openalex.org/W2146136250","https://openalex.org/W2151774137","https://openalex.org/W2156687558","https://openalex.org/W2159957679","https://openalex.org/W2164036335","https://openalex.org/W2321413400","https://openalex.org/W2389419101","https://openalex.org/W2423560351","https://openalex.org/W2955504961","https://openalex.org/W2975588506","https://openalex.org/W2980015831","https://openalex.org/W3009949247","https://openalex.org/W4211207317","https://openalex.org/W4297309719","https://openalex.org/W4302219957"],"related_works":["https://openalex.org/W1991104265","https://openalex.org/W2037900014","https://openalex.org/W2041959157","https://openalex.org/W1921215979","https://openalex.org/W2154122162","https://openalex.org/W2418487072","https://openalex.org/W1997323294","https://openalex.org/W4297309719","https://openalex.org/W2011327495"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015069495","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
